Surgalign Holdings Inc - SIC # 3842 - ORTHOPEDIC, PROSTHETIC, AND SURGICAL APPLIANCES AND SUPPLIES

Ticker Exchange SIC # Website Latest Ticker
SRGA Nasdaq 3842 https://www.surgalign.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Surgalign Holdings Inc

Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023 - Mar 21st, 2023 12:30 pm
Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption - Mar 20th, 2023 12:30 pm
Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023 - Mar 16th, 2023 12:30 pm
Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging - Mar 13th, 2023 12:30 pm
Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance - Mar 6th, 2023 1:30 pm
Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas - Mar 3rd, 2023 1:30 pm
Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO Portal Surgical Guidance System - Mar 2nd, 2023 1:30 pm
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million - Mar 1st, 2023 2:15 pm
Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System - Dec 15th, 2022 1:30 pm
Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia - Dec 13th, 2022 5:00 pm
Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Nov 16th, 2022 9:05 pm
Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Nov 14th, 2022 1:00 pm
Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas - Nov 9th, 2022 1:30 pm
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook - Nov 2nd, 2022 8:01 pm
Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022 - Oct 25th, 2022 12:30 pm
Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System - Oct 11th, 2022 12:30 pm
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Oct 6th, 2022 12:30 pm
Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures - Sep 26th, 2022 12:30 pm
Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System - Sep 15th, 2022 12:30 pm
Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting - Sep 8th, 2022 6:00 pm